150 related articles for article (PubMed ID: 33087273)
1. Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum.
Lehmann AR; Fassihi H
DNA Repair (Amst); 2020 Sep; 93():102907. PubMed ID: 33087273
[TBL] [Abstract][Full Text] [Related]
2. Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.
Garcia-Moreno H; Langbehn DR; Abiona A; Garrood I; Fleszar Z; Manes MA; Morley AMS; Craythorne E; Mohammed S; Henshaw T; Turner S; Naik H; Bodi I; Sarkany RPE; Fassihi H; Lehmann AR; Giunti P
Brain; 2023 Dec; 146(12):5044-5059. PubMed ID: 38040034
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
4. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.
Broughton BC; Berneburg M; Fawcett H; Taylor EM; Arlett CF; Nardo T; Stefanini M; Menefee E; Price VH; Queille S; Sarasin A; Bohnert E; Krutmann J; Davidson R; Kraemer KH; Lehmann AR
Hum Mol Genet; 2001 Oct; 10(22):2539-47. PubMed ID: 11709541
[TBL] [Abstract][Full Text] [Related]
5. Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes.
Queille S; Drougard C; Sarasin A; Daya-Grosjean L
J Invest Dermatol; 2001 Nov; 117(5):1162-70. PubMed ID: 11710928
[TBL] [Abstract][Full Text] [Related]
6. Xeroderma pigmentosum in the United kingdom.
Lehmann AR
Photochem Photobiol; 2015; 91(2):484-5. PubMed ID: 24943090
[TBL] [Abstract][Full Text] [Related]
7. Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.
Frederick GD; Amirkhan RH; Schultz RA; Friedberg EC
Hum Mol Genet; 1994 Oct; 3(10):1783-8. PubMed ID: 7849702
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum clinical practice guidelines.
Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
[TBL] [Abstract][Full Text] [Related]
9. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
10. [Xeroderma pigmentosum].
Ueda M; Ichihashi M
Nihon Rinsho; 1995 Nov; 53(11):2815-20. PubMed ID: 8538050
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
Moriwaki S; Kraemer KH
Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
[TBL] [Abstract][Full Text] [Related]
12. Strict sun protection results in minimal skin changes in a patient with xeroderma pigmentosum and a novel c.2009delG mutation in XPD (ERCC2).
Emmert S; Ueda T; Zumsteg U; Weber P; Khan SG; Oh KS; Boyle J; Laspe P; Zachmann K; Boeckmann L; Kuschal C; Bircher A; Kraemer KH
Exp Dermatol; 2009 Jan; 18(1):64-8. PubMed ID: 18637129
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
14. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
15. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency.
Tanaka K; Kamiuchi S; Ren Y; Yonemasu R; Ichikawa M; Murai H; Yoshino M; Takeuchi S; Saijo M; Nakatsu Y; Miyauchi-Hashimoto H; Horio T
Mutat Res; 2001 Jun; 477(1-2):31-40. PubMed ID: 11376684
[TBL] [Abstract][Full Text] [Related]
16. Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes.
Schäfer A; Gratchev A; Seebode C; Hofmann L; Schubert S; Laspe P; Apel A; Ohlenbusch A; Tzvetkov M; Weishaupt C; Oji V; Schön MP; Emmert S
Exp Dermatol; 2013 Jul; 22(7):486-9. PubMed ID: 23800062
[TBL] [Abstract][Full Text] [Related]
17. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
19. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
